Galena Biopharma fka GALE

[Euripides90]

Amen! Positive outlook for Gale's Breast Cancer drugs:


http://www.barchart.com/headlines/story/3188718/global-breast-cancer-vaccine-clinical-trial-insight


It is most likely that the first breast cancer vaccines would be introduced in market in the next 3-5 years period.

Clinical trials would be able to come with thoroughly checked version of products under investigation which would be able to provide higher levels of medical care to breast cancer patients.

Most of the innovative products are at the final stages of clinical trials which are supposed to clear the targeted end points. Global Breast Cancer Vaccine Clinical Trial Insight Report Highlight: - Global Breast Cancer Vaccine Market Overview - Global Breast Cancer Vaccine Clinical Pipeline by Company, Phase & Country - Mechanism of Breast Cancer Vaccine & Personalized Cancer Vaccines - Detailed Clinical Insight on Breast Cancer Vaccine Pipeline: 35 Vaccines - Majority in PHASE-I Clinical Trial: 12 Vaccines

- Highest Clinical Phase is PHASE-III: 2 Vaccines (NeuVax & OBI-822) Key Topics Covered: 1. Global Breast Cancer Vaccine Market Overview 2. Global Breast Cancer Vaccine Market Dynamics 3. Mechanism of Breast Cancer Vaccine 4. Personalized Cancer Vaccines: Progress & Possibilities 5. Global Breast Cancer Vaccine Market Future Prospects 6. Global Breast Cancer Vaccines Pipeline by Phase, Company & Country 7. Suspended & Discontinued Breast Cancer Vaccines Pipeline by Phase, Company & Country 8. Competitive Landscape - AlphaVax - Galena Biopharma - Generex Biotechnology - GlaxoSmithKline - Immune Design - Immunovaccine - Immunovative Therapies - Imugene - TapImmune - ViroMed For more information visit http://www.researchandmarkets.com/research/z2zwt4/global_breast